AgriGenome Labs Pvt Ltd

aggenom.com

AgriGenome Labs (AgGenome) was started in 2013 as a division of SciGenom Labs and after successful incubation, it became an independent company in 2015 with facilities in Genome Valley, Hyderabad and "SmartCity Kochi"​, Cochin. Both the facilities are equipped with state-of-the-art instruments and provide genome sequencing, editing and bioinformatics services for Plant, Animal & Microbial projects of the industry as well as academic and government institutions. AgGenome genomics platforms include PacBio Sequel (first installation in Asia), Illumina sequencers, ABI 3730xl Sanger sequencers and more.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

INDUSTRIAL IMPACT

C-LECTA ANNOUNCES THAT IT HAS REACHED AGREEMENT TO BE ACQUIRED BY KERRY GROUP

c-LEcta | February 16, 2022

news image

c-LEcta, a leading biotechnology company in enzyme engineering and bioprocess development, has announced that it has reached an agreement with Kerry Group for it to acquire a majority shareholding of the company. Kerry is a world-leading taste and nutrition partner for the food, beverage, and pharmaceutical markets. This strategically compelling combination will accelerate Kerry’s innovation capabilities in enzyme engineering, fermentation and bio-process development while also enabling c-...

Read More

GLAXOSMITHKLINE TEAMS WITH VIR BIOTECHNOLOGY TO DEVELOP CORONAVIRUS VACCINE, TREATMENTS

The Business Journals | April 06, 2020

news image

GlaxoSmithKline and Vir Biotechnology Inc. said Monday they have signed a binding coronavirus research and development agreement. As part of the agreement, GlaxoSmithKline (NYSE: GSK) will invest $250 million in Vir (NASDAQ: VIR). GlaxoSmithKline, based in London, has large operations in Philadelphia and Montgomery County. Vir is based in San Francisco. Shares in Vir jumped almost 27% to close at $36.70 Monday. GSK's stock price finished up 2% to $37.91. The collaboration will seek to use Vi...

Read More

RESEARCH SOLUTIONS ANNOUNCES PARTNERSHIP WITH BIO BUSINESS SOLUTIONS TO BRING ONE-CLICK SCIENTIFIC LITERATURE ACCESS TO THE BIOTECH INDUSTRY

Research Solutions | October 12, 2020

news image

Research Solutions/Reprints Desk (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, today announced that it has partnered with BIO Business Solutions to help life sciences companies save time and money on scholarly literature access via its award-winning Article Galaxy research platform. Operated by the Biotechnology Innovation Organization (BIO), BIO Business Solutions is the industry's largest cost savings purchasing program. More than 4...

Read More

LEXOGEN AND ONRAMP BIOINFORMATICS PARTNER TO PROVIDE DIFFERENTIAL GENE EXPRESSION DATA ANALYSIS AND INTERPRETATION FOR QUANTSEQ 3' MRNA-SEQ USERS

Lexogen | June 17, 2020

news image

Lexogen, a transcriptomics and Next Generation Sequencing company, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis and collaboration tools, announced availability for the QuantSeq 3' mRNA-Seq data analysis pipeline on ROSALIND™, the globally recognized discovery platform for scientists and researchers. The partnership enhances QuantSeq 3' mRNA-Seq data analysis with ROSALIND's visual data exploration and deep pathway interpretation with more than 50 knowle...

Read More
news image

INDUSTRIAL IMPACT

C-LECTA ANNOUNCES THAT IT HAS REACHED AGREEMENT TO BE ACQUIRED BY KERRY GROUP

c-LEcta | February 16, 2022

c-LEcta, a leading biotechnology company in enzyme engineering and bioprocess development, has announced that it has reached an agreement with Kerry Group for it to acquire a majority shareholding of the company. Kerry is a world-leading taste and nutrition partner for the food, beverage, and pharmaceutical markets. This strategically compelling combination will accelerate Kerry’s innovation capabilities in enzyme engineering, fermentation and bio-process development while also enabling c-...

Read More
news image

GLAXOSMITHKLINE TEAMS WITH VIR BIOTECHNOLOGY TO DEVELOP CORONAVIRUS VACCINE, TREATMENTS

The Business Journals | April 06, 2020

GlaxoSmithKline and Vir Biotechnology Inc. said Monday they have signed a binding coronavirus research and development agreement. As part of the agreement, GlaxoSmithKline (NYSE: GSK) will invest $250 million in Vir (NASDAQ: VIR). GlaxoSmithKline, based in London, has large operations in Philadelphia and Montgomery County. Vir is based in San Francisco. Shares in Vir jumped almost 27% to close at $36.70 Monday. GSK's stock price finished up 2% to $37.91. The collaboration will seek to use Vi...

Read More
news image

RESEARCH SOLUTIONS ANNOUNCES PARTNERSHIP WITH BIO BUSINESS SOLUTIONS TO BRING ONE-CLICK SCIENTIFIC LITERATURE ACCESS TO THE BIOTECH INDUSTRY

Research Solutions | October 12, 2020

Research Solutions/Reprints Desk (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, today announced that it has partnered with BIO Business Solutions to help life sciences companies save time and money on scholarly literature access via its award-winning Article Galaxy research platform. Operated by the Biotechnology Innovation Organization (BIO), BIO Business Solutions is the industry's largest cost savings purchasing program. More than 4...

Read More
news image

LEXOGEN AND ONRAMP BIOINFORMATICS PARTNER TO PROVIDE DIFFERENTIAL GENE EXPRESSION DATA ANALYSIS AND INTERPRETATION FOR QUANTSEQ 3' MRNA-SEQ USERS

Lexogen | June 17, 2020

Lexogen, a transcriptomics and Next Generation Sequencing company, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis and collaboration tools, announced availability for the QuantSeq 3' mRNA-Seq data analysis pipeline on ROSALIND™, the globally recognized discovery platform for scientists and researchers. The partnership enhances QuantSeq 3' mRNA-Seq data analysis with ROSALIND's visual data exploration and deep pathway interpretation with more than 50 knowle...

Read More